ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ASRT Assertio Holdings Inc

0.80
-0.0079 (-0.98%)
08 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Assertio Holdings Inc NASDAQ:ASRT NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0079 -0.98% 0.80 0.7949 0.8099 0.808 0.778 0.805 558,896 00:50:47

Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024

30/10/2024 12:00pm

GlobeNewswire Inc.


Assertio (NASDAQ:ASRT)
Historical Stock Chart


From Aug 2024 to Feb 2025

Click Here for more Assertio Charts.

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will release third quarter 2024 financial results on Monday, November 11, 2024, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.

To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-646-307-1963. The call ID is 3278948.

A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

About AssertioAssertio is a commercial pharmaceutical company offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact Matt KrepsDarrow Associates Investor Relations+1-214-597-8200mkreps@darrowir.com  

1 Year Assertio Chart

1 Year Assertio Chart

1 Month Assertio Chart

1 Month Assertio Chart

Your Recent History

Delayed Upgrade Clock